Tagged with Consultancy

Ireland Aidan Meagher, Tax Partner & Irish Life Sciences Lead for EY Ireland, discusses EY’s extensive consulting work, including their efforts to promote entrepreneurship in Ireland, the changing landscape facing the medtech industry in the country as well as how Ireland can work to make itself an even more attractive destination…

Philippines Ravinder S. Singha, the Managing Director of Firmlink Pharma, discusses the unique business model they offer to their clients, their key success factors in entering new and sometimes challenging markets, as well as his views on the potential seen in many of the dynamic pharma markets around the world. He…

Philippines Jingle Garcia Diola, Executive Director at Firmlink Pharma, details the company’s value-added services and how they are positioning themselves as the business development partner of choice for large local and multinational companies looking to penetrate new markets. She also discusses her extensive career in the pharmaceutical industry as well as…

Slovakia Deloitte Slovakia’s Chairman, Vladimir Masar, talks about the transferability of his financial banking experience to the consultancy sector, the country’s attractiveness to foreign investment and the current state of its healthcare system. Given your extensive experience of the public and private sectors, could you tell our global executive readers about…

Mexico Jorge Romero Castañeda and María Eugenia Mendez, Healthcare & Life Science leader and Strategy & Operations Director at Deloitte respectively, share their expertise about the Healthcare & Life Science sector in Mexico and showcase the integral solutions that the firm offers to the industry to help companies gain competitiveness as…

Singapore HGP Partner and Director of Asia, Ming Chua on the company’s reasons for using Singapore as the first point of entry into Asia, while highlighting the expansion of the country’s biomedical sciences sector as a major factor in HGP’s consistent year-on-year growth. He also speaks to the company’s qualities in…

Luxembourg Deloitte’s Luc Brucher delves into market integration efforts in Luxembourg, Europe’s ‘test-bed,’ for a new and unique approach to healthcare. Committed to creating innovative medical solutions, Brucher explains why Deloitte are seeking both short and long-term results. The life sciences sector in Luxembourg represents an emerging and evolving market with…

Ireland Jack Daly, Commercial Manager at IMS Health Ireland, discusses the strategic decision of IMS Health to diversify into the health consultancy space, the importance of developing long-term partnerships with clients instead of transactional interactions, and the most important trends he sees in the Irish market today. To begin, could you…

Pharma KPMG is committed to providing long-term support to public as well as private institutions as they tackle challenges and transform the way healthcare is provided. Alberto De Negri, partner of the healthcare practice, discusses his perspective about the Italian healthcare system and the challenges it is currently facing. What have…

Pharma Roland Berger’s Patrick Biecheler discusses the French healthcare system, their role in offering specialized consultancy services to the pharmaceutical sector, and the digitalization of the healthcare industry.  Can you please start by giving us a brief overview of Roland Berger’s “Healthcare Competence Centre”, the rationale behind basing it in France,…

Pharma PwC France’s pharma and life sciences industry leader speaks out about the consultancy’s positioning as partner of choice for advisory services in the pharmaceutical industry with more than 75 percent of the local market now registered as clients. She also reflects upon the likely repercussions of digital disruption on the…

Pharma Anna Van Poucke, Partner and Chairman at KPMG Healthcare in the Netherlands, explains how KPMG can helps its partners and clients move forward towards a better integrated, more efficient and smartly designed healthcare eco-system, while remaining at the forefront of the industry in terms of M&A, supply chain and cultural…